{"prompt": "['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix D: Scalp Physician Global Assessment (ScPGA)', 'Score', 'Category', 'Category Description', '0', 'Clear', 'Scalp Plaque Elevation = 0 (no elevation over normal skin)', 'Scalp Scaling = 0 (no evidence of scaling)', 'Scalp Erythema = 0 (except for residual', 'lyperpigmentation/hypopigmentation)', '1', 'Almost', 'Scalp Plaque Elevation = (possible but difficult to ascertain', 'Clear', 'whether there is a slight elevation above normal skin)', 'Scalp Scaling = (surface dryness with some desquamation)', 'Scalp Erythema = (faint, diffuse pink or slight red coloration)', '2', 'Mild', 'Scalp Plaque Elevation = slight (slight but definite elevation,', 'typically edges are indistinct or sloped)', 'Scalp Scaling = fine (fine scale partially or mostly covering lesions)', 'Scalp Erythema = mild (light red coloration)', '3', 'Moderate', 'Scalp Plaque Elevation = marked (marked definite elevation with', 'rough or sloped edges)', 'Scalp Scaling = coarser (coarser scale covering most or all of the', 'lesions)', 'Scalp Erythema = moderate (definite red coloration)', '4', 'Severe', 'Scalp Plaque Elevation = marked (marked elevation typically with', 'hard or sharp edges)', 'Scalp Scaling = coarser (coarse, non tenacious scale predominates', 'covering most or all of the lesions)', 'Scalp Erythema = severe (very bright red coloration)', 'Confidential and Proprietary', '78', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix E: Nail Psoriasis Severity Index (NAPSI)', 'The target thumb or finger nail which represents the worst nail', 'psoriasis is graded for nail matrix psoriasis and nail bed psoriasis.', 'The sum of these two scores is the total score for that nail.', 'Evaluation 1: Nail matrix. In each quadrant of', 'the nail, nail matrix psoriasis is evaluated by', 'presence of any of the nail matrix features', '(pitting, leukonychia red spots in the lunula,', 'crumbling):', 'Score for nail matrix psoriasis', '0 = none', '1 = present in 1/4 nail', '2 = present in 2/4 nail', '3 = present in 3/4 nail', '4 = present in 4/4 nail', 'Evaluation 2: Nail bed. Nail bed psoriasis is', 'evaluated by the presence of any of the nail bed', 'features (onycholysis, splinter hemorrhages,', 'subungual hyperkeratosis, \"oil drop\" (salmon', 'patch dyschroma):', 'Score for nail bed psoriasis', '0 = none', '1 = present in 1/4 nail', '2 = present in 2/4 nail', '3 = present in 3/4 nail', '4 = present in 4/4 nail', 'TOTAL FOR NAIL', '(0-8)', 'Source: Rich, 2003.', 'Confidential and Proprietary', '79', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']['Apremilast', 'Protocol CC-10004-PSOR-020', 'Amgen Inc.', 'Appendix F: Modified Static Physicians Global Assessment of Genitalia', '(Modified sPGA-G)', 'The Modified Static Physician Global Assessment of Genitalia', 'Score\u00b9', 'Category', 'Category Description\u00b2', 'Erythema: no erythema (except for residual', 'hyperpigmentation/ hypopigmentation)', '0', 'Clear', 'Plaque elevation: no elevation', 'Scaling: no scale', 'Erythema: faint, light pink erythema', '1', 'Almost Clear', 'Plaque elevation: elevation is very slight and difficult to', 'confirm', 'Scaling: some fine, white surface dryness', 'Erythema: mild, pink erythema', '2', 'Mild', 'Plaque elevation: slight elevation with sloped edges', 'Scaling: fine scale on some or most lesions', 'Erythema: moderate, red erythema', '3', 'Moderate', 'Plaque elevation: moderate elevation with definite edges', 'that are either sloped or rough', 'Scaling: coarse scale on most lesions', 'Erythema: severe, bright or deep red erythema', '4', 'Severe', 'Plaque elevation: substantial elevation, hard and sharp', 'edges', 'Scaling: coarse, non-adherent scale on most to all lesions', 'Adapted from source: Merola, 2017.', 'Confidential and Proprietary', '80', 'CC-10004-PSOR-020 Amendment 3 FINAL: 01 May 2020', 'EDMS Doc. Number: 24684941 - 22835610']\n\n###\n\n", "completion": "END"}